Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL342278 | 0.91 | ERN1 (0.57) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL29388184 | 0.91 | ERN1 (0.57) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL10348702 | 0.89 | ERN1 (0.55) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| Methyl Alcohol SCHEMBL27670101 | 0.85 | ERN1 (0.57) | ERN1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL11483755 | 0.85 | ERN1 (0.50) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL9883837 | 0.84 | ERN1 (0.48) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL31317593 | 0.83 | ERN1 (0.43) | ERN1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL28218594 | 0.82 | KIF11 (0.47) | ERN1ALDH1A1HSD17B10MAPTCYP1A2 | |
| SCHEMBL8601328 | 0.81 | ERN1 (0.49) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL5748403 | 0.81 | ALDH1A1 (0.48) | ERN1ALDH1A1HSD17B10HIF1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4728836-A1 | PEROVSKITE MATERIAL AND USES THEREOF | Victoria Link Limited (NZ) | 2026-04-22 | — | — | EP | disclosed |
| US-20250011264-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | SUMITOMO BAKELITE CO., LTD. (JP) | 2025-01-09 | — | — | US | disclosed |
| WO-2024258297-A1 | PEROVSKITE MATERIAL AND USES THEREOF | VICTORIA LINK LIMITED (NZ) | 2024-12-19 | — | — | WO | disclosed |
| EP-4434960-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | Sumitomo Bakelite Co., Ltd. (JP) | 2024-09-25 | — | — | EP | disclosed |
| CN-118265685-A | Cyclic compound and method for producing cyclic compound | 住友电木株式会社 | 2024-06-28 | — | — | CN | disclosed |
| WO-2023090298-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | 住友ベークライト株式会社 | 2023-05-25 | — | — | WO | disclosed |
| CN-113412261-A | Benzimidazole compounds, preparation method and use thereof | 四川科伦博泰生物医药股份有限公司 | 2021-09-17 | — | — | CN | disclosed |
| US-20080044149-A1 | Polymerizable Composition | TOYO INK MFG. CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1816152-A1 | POLYMERIZABLE COMPOSITION | TOYO INK MFG. CO., LTD. (JP) | 2007-08-08 | — | — | EP | disclosed |
| EP-0182609-B1 | POLYCYCLIC BIOCIDAL COMPOUNDS, THEIR SYNTHESIS, FORMULATIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-05-09 | — | — | EP | disclosed |
| US-4827034-A | ANTITUMOR | BURROUGHS WELLCOME CO. (US) | 1989-05-02 | — | — | US | disclosed |
| US-4818443-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-04-04 | — | — | US | disclosed |
| US-4814502-A | ANTITUMOR AGENTS, ANTICARCINOGENIC AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-03-21 | — | — | US | disclosed |
| US-4810823-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-03-07 | — | — | US | disclosed |
| US-4808753-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-02-28 | — | — | US | disclosed |
| US-4791233-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1988-12-13 | — | — | US | disclosed |
| US-4791231-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1988-12-13 | — | — | US | disclosed |
| US-4791232-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1988-12-13 | — | — | US | disclosed |
| EP-0182609-A2 | Polycyclic biocidal compounds, their synthesis, formulations containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-05-28 | — | — | EP | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250011264-A1 | CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND | CA1, ASIC1, CA7 | ERN1 1956/4885ALDH1A1 1024/4885HSD17B10 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.